Dataset from A Randomized, Double-blind, Two Treatment, Two Period, Chronic Dosing (4 Weeks), Crossover, Multi-center Pilot Study to Evaluate the Effects of Budesonide/Glycopyrronium/Formoterol Fumarate and Glycopyrronium/Formoterol Fumarate on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD

This is a randomised, controlled, two period cross-over, 4 weeks chronic dosing, study to
evaluate the effects of Budesonide/Glycopyrronium/Formoterol Fumarate (BGF) and
Glycopyrronium/Formoterol Fumarate (GFF) on airway dimensions.

本研究为一项采用随机对照、两周期交叉设计的4周慢性给药试验，旨在评估布地奈德/格隆溴铵/富马酸福莫特罗（Budesonide/Glycopyrronium/Formoterol Fumarate, BGF）与格隆溴铵/富马酸福莫特罗（Glycopyrronium/Formoterol Fumarate, GFF）对气道径线的影响。